Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 43(114), 2017

DOI: 10.1073/pnas.1708122114

Links

Tools

Export citation

Search in Google Scholar

PAF promotes stemness and radioresistance of glioma stem cells

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Significance Glioblastoma multiforme (GBM) is uniformly lethal and shows resistance to all forms of therapy. Glioma stem cells (GSCs) have been shown to support GBM maintenance and exhibit enhanced resistance to ionizing radiation, a cornerstone of GBM therapy. This study establishes that proliferating cell nuclear antigen-associated factor (PAF) depletion profoundly reduces GSC frequency and tumorigenicity, in part, by down-regulating DNA replication and pyrimidine metabolism. Moreover, PAF depletion impairs error-prone DNA translesion synthesis (TLS) and enhances sensitivity of GSCs to radiation treatment. Pharmacological impairment of DNA replication and TLS diminished GSC maintenance and radioresistance, illuminating a potential GBM treatment strategy of combined TLS inhibition and radiation therapy.